Syk deficiency enhances the production of IFNβ and IL-10 through promoting the activity of PI3K–Akt–GSK3β signaling.
Syk deficiency decreases the production of pro-inflammatory cytokines through suppressing the activity of NF-κB.
Syk is a novel innate regulator and potential intervention target for the control of inflammatory responses.